NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I agree, and Amgen is certainly a leader, but I don't believe they intend to take things nearly as far as NWBO is. I'm saying they're looking to find markers found in many patients, and build products for those patients, but still a mass produced product. It will certainly be more effective than one drug intended for all patients regardless of their markers, but not as effective as a vaccine that's made from the cancer it's fighting intended for one, and only one, patient.

If you break a disease like say pancreatic cancer to ten separate groups distinguishable by certain markers it should be more effective than a single drug targeted at it. Together with DCVax-L it could make the difference in curing or dramatically prolonging survival.

I don't know that BP's will ever work to develop totally personalized products themselves, but I'd not be surprised for them to acquire companies that did, but I believe they'll keep them in wholly owned subsidiaries which may continue to develop new products. I suppose if they wished to do it themselves, they too could establish wholly owned subsidiaries essentially keeping the personalized products separate from the mass produced products.

Gary